News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lupin Ltd. (LUPN.BO) Said to Consider Sale of Indian Drugs Unit; Deal May Reap $1 Billion


7/18/2011 7:17:54 AM

Lupin Ltd. (LPC), the world’s largest maker of drugs to fight tuberculosis, is considering selling its unit that markets medicines in India, said two people with knowledge of the matter. Founding shareholders who own a combined 47 percent of the Mumbai-based company have started the process of finding a buyer for the operations, said the people, who declined to be identified because the discussions are private. The Indian business may be worth at least $1 billion, one person said. ling the Indian medicines unit, which accounted for 32 percent of Lupin’s 57.1 billion rupees ($1.3 billion) of revenue in the year ended March 31, may help finance investments in more profitable markets overseas.

Read at Bloomberg
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES